These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17416553)

  • 1. Ex vivo gene therapy cures a blistering skin disease.
    Featherstone C; Uitto J
    Trends Mol Med; 2007 Jun; 13(6):219-22. PubMed ID: 17416553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy approaches for epidermolysis bullosa.
    Ferrari S; Pellegrini G; Mavilio F; De Luca M
    Clin Dermatol; 2005; 23(4):430-6. PubMed ID: 16023940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of inherited skin adhesion disorders: a critical overview.
    De Luca M; Pellegrini G; Mavilio F
    Br J Dermatol; 2009 Jul; 161(1):19-24. PubMed ID: 19466960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited epidermolysis bullosa. Clinical features, molecular genetics, and pathoetiologic mechanisms.
    Uitto J; Christiano AM
    Dermatol Clin; 1993 Jul; 11(3):549-63. PubMed ID: 8365039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited epidermolysis bullosa: past, present, and future.
    Fine JD
    Ann N Y Acad Sci; 2010 Apr; 1194():213-22. PubMed ID: 20536471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First trimester embryo-fetoscopic and ultrasound-guided fetal blood sampling for ex vivo viral transduction of cultured human fetal mesenchymal stem cells.
    Chan J; Kumar S; Fisk NM
    Hum Reprod; 2008 Nov; 23(11):2427-37. PubMed ID: 18687673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional therapies for cutaneous wound repair in epidermolysis bullosa.
    Peking P; Koller U; Murauer EM
    Adv Drug Deliv Rev; 2018 Apr; 129():330-343. PubMed ID: 29248480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of inherited skin-blistering disorders, and therapeutic implications.
    Aumailley M; Has C; Tunggal L; Bruckner-Tuderman L
    Expert Rev Mol Med; 2006 Oct; 8(24):1-21. PubMed ID: 17040578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous gene transfer and therapy: the present and the future.
    Spirito F; Meneguzzi G; Danos O; Mezzina M
    J Gene Med; 2001; 3(1):21-31. PubMed ID: 11269332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer.
    Ortiz-Urda S; Lin Q; Yant SR; Keene D; Kay MA; Khavari PA
    Gene Ther; 2003 Jul; 10(13):1099-104. PubMed ID: 12808440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained phenotypic reversion of junctional epidermolysis bullosa dog keratinocytes: Establishment of an immunocompetent animal model for cutaneous gene therapy.
    Spirito F; Capt A; Del Rio M; Larcher F; Guaguere E; Danos O; Meneguzzi G
    Biochem Biophys Res Commun; 2006 Jan; 339(3):769-78. PubMed ID: 16316622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Gene/Cell Therapy in Epidermolysis Bullosa.
    Murauer EM; Koller U; Pellegrini G; De Luca M; Bauer JW
    Keio J Med; 2015; 64(2):21-5. PubMed ID: 26050701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hereditary blistering diseases. Symptoms, diagnosis and treatment of epidermolysis bullosa].
    Laimer M; Lanschützer CM; Nischler E; Klausegger A; Diem A; Pohla-Gubo G; Bauer JW; Hintner H
    Hautarzt; 2009 May; 60(5):378-88. PubMed ID: 19430749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy in combination with tissue engineering to treat epidermolysis bullosa.
    Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
    Expert Opin Biol Ther; 2006 Apr; 6(4):367-78. PubMed ID: 16548763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy.
    Gostynski A; Deviaene FC; Pasmooij AM; Pas HH; Jonkman MF
    Br J Dermatol; 2009 Aug; 161(2):444-7. PubMed ID: 19416258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a gene therapy clinical trial for epidermolysis bullosa.
    Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
    Rev Recent Clin Trials; 2006 May; 1(2):155-62. PubMed ID: 18473966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermolysis bullosa: directions for future research and new challenges for treatment.
    Sawamura D; McMillan JR; Akiyama M; Shimizu H
    Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S34-42. PubMed ID: 12677431
    [No Abstract]   [Full Text] [Related]  

  • 18. EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure.
    Uitto J; Bruckner-Tuderman L; McGrath JA; Riedl R; Robinson C
    J Invest Dermatol; 2018 May; 138(5):1010-1016. PubMed ID: 29391251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One goal, different strategies--molecular and cellular approaches for the treatment of inherited skin fragility disorders.
    Hünefeld C; Mezger M; Kern JS; Nyström A; Bruckner-Tuderman L; Müller I; Handgretinger R; Röcken M
    Exp Dermatol; 2013 Mar; 22(3):162-7. PubMed ID: 23489418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of severe epidermolysis bullosa by haematopoietic transplant: principles, perspectives and pitfalls.
    Tolar J; Wagner JE
    Exp Dermatol; 2012 Dec; 21(12):896-900. PubMed ID: 23016552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.